RAPHAS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,570 KRW | -2.18% |
|
-5.49% | -34.84% |
| May. 14 | Tranche Update on Raphas Co., Ltd.'s Equity Buyback Plan announced on February 15, 2024. | CI |
| Feb. 15 | Raphas Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
| Sales 2022 | 23.64B 17.07M | Sales 2023 | 27.94B 20.17M | Capitalization | 165B 119M |
|---|---|---|---|---|---|
| Net income 2022 | -8.51B -6.14M | Net income 2023 | -8.8B -6.36M | EV / Sales 2022 | 5.27 x |
| Net cash position 2022 | 9.8B 7.07M | Net Debt 2023 | 6.89B 4.98M | EV / Sales 2023 | 6.17 x |
| P/E ratio 2022 |
-16.1
x | P/E ratio 2023 |
-18.9
x | Employees | 92 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 70.56% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.18% | ||
| 1 week | -5.49% | ||
| 1 month | -10.09% | ||
| 3 months | -22.69% | ||
| 6 months | -31.94% | ||
| Current year | -34.84% |
1 week
12 420.00
13 390.00
1 month
12 420.0014 540.00
Current year
12 420.0020 150.00
1 year
12 420.0031 450.00
3 years
12 420.0080 500.00
5 years
7 500.0080 500.00
10 years
7 500.0080 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Do-Hyeon Jeong
CEO | Chief Executive Officer | 55 | 09-04-30 |
Yong-Hui Lee
DFI | Director of Finance/CFO | 48 | 14-04-14 |
Sook-Hui Na
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Do-Hyeon Jeong
CEO | Chief Executive Officer | 55 | 09-04-30 |
Yong-Hui Lee
DFI | Director of Finance/CFO | 48 | 14-04-14 |
Joo-Yeob Shin
BRD | Director/Board Member | 48 | 15-01-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 12,570 | -2.18% | 21,521 |
| 24-05-30 | 12,850 | +2.55% | 14,533 |
| 24-05-29 | 12,530 | -3.91% | 49,721 |
| 24-05-28 | 13,040 | -0.08% | 16,462 |
| 24-05-27 | 13,050 | -1.88% | 24,816 |
End-of-day quote Korea S.E., May 30, 2024
More quotes
Raphas Co., Ltd. is a Korea-based company mainly engaged in the research, development manufacturing and distribution of microarray patches. The Company develops cosmetics based on microstructure technology. In addition, the Company sells cosmetics, pharmaceutical patches, health functional foods under the brand name of Acropass.
Sector
Personal Products
Calendar
2024-08-08
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -34.84% | 74.11M | |
| +0.32% | 262B | |
| +18.76% | 20.37B | |
| -.--% | 19.29B | |
| +16.91% | 12.64B | |
| -16.59% | 8.94B | |
| +33.93% | 8.62B | |
| +9.55% | 5.93B | |
| -12.08% | 3.92B | |
| -16.83% | 3.84B |
- Stock Market
- Equities
- A214260 Stock
